arrow
A

Albert Martínez-Pinteño

University of Barcelona
H指数:10
被引数:252

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endocannabinoid plasma concentrations and their relationship with clinical outcome and cannabis use in antipsychotic-naïve first episode psychosis

内源性大麻素血浆浓度及其与首发精神病抗精神病药物初治患者的临床结局和大麻使用的关系

2026-09-280
PRE
Increased brain VDAC1 protein levels correlate with behavioural performance in a ketamine murine model of schizophrenia and are attenuated by the mGluR2 modulator JNJ-46356479

在氯胺酮精神分裂症小鼠模型中,脑内VDAC1蛋白水平的升高与行为表现相关,且可被mGluR2调节剂JNJ-46356479减弱

2026-06-010
OAAI
Psychopathology and Other Mental Health Challenges in Siblings of Patients with Child- or Adolescent-Onset Anorexia Nervosa: A Systematic Review with a Sex/Gender Perspective

精神病理学及其他心理健康挑战:儿童或青少年期发病的神经性厌食症患者同胞的系统综述——性别视角

2026-02-270
OAAI
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophrenia

在精神分裂症中,背外侧前额叶皮层星形胶质细胞特异性基因表达与氯氮平治疗的相关性

2025-10-310
OA
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamine

JNJ-46356479和氯氮平对产后暴露于氯胺酮的小鼠中VGLUT1和GAD65/67脑水平以及与谷氨酸和GABA相关的基因表达的影响

2025-10-110
OAAI
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls
2024-04-012
OAAI
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode

首次精神病发作后认知多基因风险评分与临床进展之间的联系

2022-06-099
OAAI
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
2022-06-0112
OAAI
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
2022-04-273
OAAI
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
2022-04-019
PRE